DCX and Alzheimer disease: First, we quantified the number of DCX+ progenitor cells and, as expected, there was a significant reduction compared to controls in AD patients (C 4.2 +/− 0.6; AD 2.2 +/− 0.7; T test p = 0.03, F 0.9 (Figure 1B).